Citius Pharmaceuticals, Inc.
CTXR · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $145 | $167 | $295 | $367 |
| - Cash | $3 | $26 | $42 | $70 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | $142 | $141 | $254 | $298 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$39 | -$32 | -$33 | -$23 |
| % Margin | – | – | – | – |
| Net Income | -$39 | -$33 | -$34 | -$23 |
| % Margin | – | – | – | – |
| EPS Diluted | -5.97 | -5.57 | -5.76 | -5.64 |
| % Growth | -7.2% | 3.3% | -2.1% | – |
| Operating Cash Flow | -$28 | -$29 | -$28 | -$24 |
| Capital Expenditures | $0 | $0 | $0 | -$40 |
| Free Cash Flow | -$28 | -$29 | -$28 | -$64 |